DK3297987T3 - Nye azetidinderivater, der er anvendelige som modulatorer af kortikal cathecolaminergisk neurotransmission - Google Patents
Nye azetidinderivater, der er anvendelige som modulatorer af kortikal cathecolaminergisk neurotransmission Download PDFInfo
- Publication number
- DK3297987T3 DK3297987T3 DK16724046.4T DK16724046T DK3297987T3 DK 3297987 T3 DK3297987 T3 DK 3297987T3 DK 16724046 T DK16724046 T DK 16724046T DK 3297987 T3 DK3297987 T3 DK 3297987T3
- Authority
- DK
- Denmark
- Prior art keywords
- cortial
- cathecolamineric
- neurotransmission
- azetidin
- modulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15168373 | 2015-05-20 | ||
| SE1650485 | 2016-04-11 | ||
| PCT/EP2016/061479 WO2016185032A1 (en) | 2015-05-20 | 2016-05-20 | Novel azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3297987T3 true DK3297987T3 (da) | 2019-06-17 |
Family
ID=56026881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16724046.4T DK3297987T3 (da) | 2015-05-20 | 2016-05-20 | Nye azetidinderivater, der er anvendelige som modulatorer af kortikal cathecolaminergisk neurotransmission |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10087142B2 (da) |
| EP (1) | EP3297987B1 (da) |
| JP (1) | JP6679621B2 (da) |
| KR (1) | KR102595892B1 (da) |
| CN (1) | CN107646031B (da) |
| AU (1) | AU2016263510B2 (da) |
| CA (1) | CA2985710C (da) |
| DK (1) | DK3297987T3 (da) |
| ES (1) | ES2730890T3 (da) |
| HK (1) | HK1245251B (da) |
| IL (1) | IL255618B (da) |
| MX (1) | MX365283B (da) |
| NZ (1) | NZ737451A (da) |
| PL (1) | PL3297987T3 (da) |
| PT (1) | PT3297987T (da) |
| RU (1) | RU2716814C2 (da) |
| WO (1) | WO2016185032A1 (da) |
| ZA (1) | ZA201707936B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ737451A (en) * | 2015-05-20 | 2022-01-28 | Integrative Res Laboratories Sweden Ab | Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| ES2962865T3 (es) | 2016-11-18 | 2024-03-21 | Integrative Res Laboratories Sweden Ab | Nuevos derivados de azetidina útiles como moduladores de la neurotransmisión catecolaminérgica cortical |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1512969A1 (ru) * | 1988-02-01 | 1989-10-07 | Институт нефтехимического синтеза им.А.В.Топчиева | Способ получени N-алкилазетидинов |
| FR2805818B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant |
| EP1638939A2 (en) | 2003-06-24 | 2006-03-29 | Neurosearch A/S | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| KR20100038295A (ko) | 2007-06-05 | 2010-04-14 | 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 | 피질 카테콜아민성 신경 전달의 조정자로서의 이치환된 페닐피롤리딘 |
| CN102224135A (zh) * | 2008-11-24 | 2011-10-19 | Nsab神经研究瑞典公司分公司 | 用作皮质儿茶酚胺能神经传递调节剂的新3-苯基-氮杂环丁烷衍生物 |
| JP5716202B2 (ja) * | 2008-11-24 | 2015-05-13 | インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー | 皮質のカテコールアミン作動性神経伝達のモジュレーターとしての３−フェニル−３−メトキシピロリジン誘導体 |
| EP2367786B1 (en) * | 2008-11-24 | 2013-01-09 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Novel 1 -alkyl- 3 -hydroxy- 3 -phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| KR101273566B1 (ko) * | 2011-09-05 | 2013-06-11 | 한국과학기술연구원 | 신규한 아제티딘 유도체 및 이를 함유하는 항우울제 조성물 |
| NZ737451A (en) * | 2015-05-20 | 2022-01-28 | Integrative Res Laboratories Sweden Ab | Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
-
2016
- 2016-05-20 NZ NZ737451A patent/NZ737451A/en unknown
- 2016-05-20 MX MX2017014577A patent/MX365283B/es active IP Right Grant
- 2016-05-20 EP EP16724046.4A patent/EP3297987B1/en active Active
- 2016-05-20 KR KR1020177033560A patent/KR102595892B1/ko active IP Right Grant
- 2016-05-20 CN CN201680027679.0A patent/CN107646031B/zh active Active
- 2016-05-20 DK DK16724046.4T patent/DK3297987T3/da active
- 2016-05-20 RU RU2017140419A patent/RU2716814C2/ru active
- 2016-05-20 AU AU2016263510A patent/AU2016263510B2/en active Active
- 2016-05-20 PT PT16724046T patent/PT3297987T/pt unknown
- 2016-05-20 WO PCT/EP2016/061479 patent/WO2016185032A1/en active Application Filing
- 2016-05-20 JP JP2017560182A patent/JP6679621B2/ja active Active
- 2016-05-20 ES ES16724046T patent/ES2730890T3/es active Active
- 2016-05-20 US US15/574,796 patent/US10087142B2/en active Active
- 2016-05-20 CA CA2985710A patent/CA2985710C/en active Active
- 2016-05-20 PL PL16724046T patent/PL3297987T3/pl unknown
-
2017
- 2017-11-13 IL IL255618A patent/IL255618B/en active IP Right Grant
- 2017-11-22 ZA ZA2017/07936A patent/ZA201707936B/en unknown
-
2018
- 2018-04-04 HK HK18104487.2A patent/HK1245251B/zh unknown
- 2018-09-27 US US16/144,076 patent/US10287247B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3297987T3 (pl) | 2019-10-31 |
| AU2016263510A1 (en) | 2017-12-07 |
| ZA201707936B (en) | 2020-01-29 |
| MX2017014577A (es) | 2018-06-11 |
| RU2017140419A (ru) | 2019-06-20 |
| CA2985710C (en) | 2023-07-25 |
| US10287247B2 (en) | 2019-05-14 |
| JP6679621B2 (ja) | 2020-04-15 |
| US20190031606A1 (en) | 2019-01-31 |
| CN107646031B (zh) | 2020-11-17 |
| NZ737451A (en) | 2022-01-28 |
| AU2016263510B2 (en) | 2020-03-12 |
| EP3297987B1 (en) | 2019-05-15 |
| CA2985710A1 (en) | 2016-11-24 |
| JP2018520100A (ja) | 2018-07-26 |
| ES2730890T3 (es) | 2019-11-13 |
| RU2716814C2 (ru) | 2020-03-17 |
| CN107646031A (zh) | 2018-01-30 |
| IL255618B (en) | 2020-02-27 |
| HK1245251B (zh) | 2020-04-24 |
| MX365283B (es) | 2019-05-29 |
| EP3297987A1 (en) | 2018-03-28 |
| IL255618A (en) | 2018-01-31 |
| US20180141903A1 (en) | 2018-05-24 |
| RU2017140419A3 (da) | 2019-07-26 |
| WO2016185032A1 (en) | 2016-11-24 |
| US10087142B2 (en) | 2018-10-02 |
| PT3297987T (pt) | 2019-06-19 |
| KR102595892B1 (ko) | 2023-10-31 |
| KR20180004742A (ko) | 2018-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3472167T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
| DK3341367T3 (da) | Bicyklisk-fusionerede heteroaryl- eller arylforbindelser som irak4-modulatorer | |
| DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
| DK3292123T3 (da) | Faste former af en forbindelse, der modulerer kinaser | |
| DK3256853T3 (da) | Forudsigelse af t-celleepitoper, der er egnede til vaccination | |
| DK3188682T3 (da) | Styring af indretning, der indbefatter mekaniske arme | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK2989092T3 (da) | Quinazolinonderivater, der er anvendelige som fgfr-kinasemodulatorer | |
| DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
| DK3357919T3 (da) | Aromatiske heterocykliske forbindelser som antiinflammatoriske forbindelser | |
| DK3131902T3 (da) | Forbindelser som ROR-gamma-modulatorer | |
| DK3313838T3 (da) | Polycykliske amidderivater som cdk9-inhibitorer | |
| DK3536324T3 (da) | 4-oxo-3,4-dihydro-1,2,3-benzotriaziner som modulatorer af gpr139 | |
| DK3204378T6 (da) | N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen | |
| DK3256462T3 (da) | Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
| DK3394484T3 (da) | Overvågning af glideringstætning | |
| DK3552017T3 (da) | Forbindelser, der er anvendelige som ripk1-inhibitorer | |
| DK3022174T3 (da) | Derivater af n-urinstof-substituerede aminosyrer som formylpeptidreceptormodulatorer | |
| DK3511418T3 (da) | Fremgangsmåde til nedbrydning af mannanholdige celluloseholdige materialer | |
| DK3277690T3 (da) | Spirocykliske forbindelser |